Medgen Life Sciences
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- Undisclosed
Investors
- 4
About Medgen Life Sciences
, trading as Medgen Life Sciences, operates as a biomaterial manufacturing company that focuses on providing regenerative repair materials. It was recognized as the National High-tech Enterprise. The company has applied for 61 patents, with 12 software copyrights. Medgen Life Sciences's main business is the research and development of regenerative repair materials. The main product is inducible bone repair materials. It has two major technology platforms: hydroxyapatite regenerative product transformation and biomedical collagen cross-linking technology. The products cover orthopedics, sports medicine, dentistry, medical beauty and other fields. The company is also engaged in the original research and development and production of orthopedic sports medicine products, the agency sales of anesthesiology and orthopedic products, and overseas biomedical investment. The company generates revenue from the sales of regenerative repair materials and related service fees. Also, it will accelerate technological innovation and the launch of consumer medical products, and continuously invest in and upgrade its independent innovation and industrial transformation platform for regenerative medicine materials.
Who invested in Medgen Life Sciences
4 investors across 3 rounds
See all investors in Medgen Life Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Medgen Life Sciences
Who invested in Medgen Life Sciences?
Medgen Life Sciences has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Medgen Life Sciences raised?
Medgen Life Sciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Medgen Life Sciences last raise money?
Medgen Life Sciences's most recent round on record is a Series B, in Jun 2026.
What does Medgen Life Sciences do?
, trading as Medgen Life Sciences, operates as a biomaterial manufacturing company that focuses on providing regenerative repair materials.
Where is Medgen Life Sciences headquartered?
Medgen Life Sciences is headquartered in Shenzhen, China.
Which VCs invest in companies like Medgen Life Sciences?
Among active investors with capital left to deploy, Yufu Capital, ICBC Capital Management, Ningbo Tongshang Fund and Boc Private Equity Firm back materials companies at Medgen Life Sciences's stage. Their profiles are linked below.
VCs backing materials startups at Series B
Raising like Medgen Life Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.